Trial intelligence / Profile preview

Magnesium Oxide and Letrozole in Subfertile Women With Insulin Resistant PCOS

NCT07766590Completed

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Jun 2025
Primary completion
May 2026
Countries
1
01

Overview

Randomised trial of magnesium oxide in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Ovulation rate at Day 21, Proportion of patients developing mature follicle and 1 more. Started Jun 2025; status: completed.

02

Drugs

magnesium oxide
03

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on NCT07766590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07766590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call